Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Cost Comparison of Ruxolitinib and Momelotinib in Patients with Myelofibrosis and Anemia

Aaron T. Gerds, Jingbo Yu, Charles Tao, Rashad Carlton, Evan M. Braunstein, Ruben A. Mesa

Blood (2024) 144 (Supplement 1): 6655.

https://doi.org/10.1182/blood-2024-193686

Published: 2024

Journal Articles

High Molecular Risk Mutations (HMR) Drive Progression of CALR -mutated Myeloproliferative Neoplasm (MPN)

Resham Mawalkar, Hua-Ling Tsai, Terra Marie M Jouaneh, Shivam Patel, Christopher Gocke, Eitan Halper-Stromberg, Rena R. Xian, K. C. Rappazzo, Evan M. Braunstein, Alison R. Moliterno, Tania Jain

Blood (2024) 144 (Supplement 1): 3173.

https://doi.org/10.1182/blood-2024-194860

Published: 2024

Journal Articles

Use of Natural Language Processing to Identify Myeloid/Lymphoid Neoplasm Patients with Fibroblast Growth Factor Receptor 1 Alterations

Sumit Verma, Mike Blecker, Thomas Edwards, Meg Richards, Shreekant V. Parasuraman, Evan M. Braunstein, Pankit Vachhani

Blood (2024) 144 (Supplement 1): 7900.

https://doi.org/10.1182/blood-2024-199205

Published: 2024

Journal Articles

Genetic or Epigenetic CR1 Deficiency Defines Catastrophic Antiphospholipid Syndrome (CAPS) and Response to Complement Inhibition

Nikhil Ranjan, Michael Cole, Gloria F. Gerber, Shruti Chaturvedi, Mark A. Crowther, Evan M. Braunstein, Daniel Flores-Guerrero, Alexis Reed, Michelle Petri, Keith R. McCrae, Robert A. Brodsky

Blood (2024) 144 (Supplement 1): 138.

https://doi.org/10.1182/blood-2024-207793

Published: 2024

Journal Articles

Molecular Predictors of Disease Progression to Myelofibrosis (MF) in Patients (Pts) with Polycythemia Vera (PV) Enrolled in Reveal

Stephen T. Oh, Jeffrey I. Zwicker, Kamal Patel, Erin L. Crowgey, Cynthia Timmers, Patricia Feldman, Justine Carl, J.E. Hamer-Maansson, Valkal Bhatt, Evan M. Braunstein, Michael R. Grunwald

Blood (2024) 144 (Supplement 1): 3145.

https://doi.org/10.1182/blood-2024-199195

Published: 2024

Journal Articles

Real-World Treatment Patterns and Blood Count Control in Patients with Polycythemia Vera Who Switched from Hydroxyurea to Ruxolitinib

Naveen Pemmaraju, Jingbo Yu, Anupama Vasudevan, Husain Qureshi, Evan M. Braunstein, Aleksander L. Chojecki

Blood (2024) 144 (Supplement 1): 3813.

https://doi.org/10.1182/blood-2024-205193

Published: 2024

Journal Articles

Clinical and Molecular Characterization of Disease Progression in Patients (Pts) with Low-Risk Myelofibrosis (MF) Enrolled in the MOST Study

Abdulraheem Yacoub, Ellen K. Ritchie, Naveen Pemmaraju, Richard Zuniga, Erin L. Crowgey, Cynthia Timmers, Patricia Feldman, J.E. Hamer-Maansson, Tricia Kalafut, Evan M. Braunstein, John O. Mascarenhas

Blood (2024) 144 (Supplement 1): 3136.

https://doi.org/10.1182/blood-2024-199810

Published: 2024

Journal Articles

Clinical Outcomes in Patients with Myelofibrosis Treated with Ruxolitinib and Anemia-Supporting Medications

Pankit Vachhani, Jennifer Repp, JE Hamer-Maansson, Evan M. Braunstein, Valkal Bhatt, Haifa Kathrin Al-Ali

Blood (2024) 144 (Supplement 1): 4546.

https://doi.org/10.1182/blood-2024-203924

Published: 2024

Journal Articles

Effect of New or Worsening Anemia on Clinical Outcomes in 2233 Patients with Myelofibrosis Treated with Ruxolitinib in the Expanded-Access Jump Study

Vikas Gupta, Paola Guglielmelli, JE Hamer-Maansson, Evan M. Braunstein, Haifa Kathrin Al-Ali

Blood (2023) 142 (Supplement 1): 5174.

https://doi.org/10.1182/blood-2023-179417

Published: 2023

Journal Articles

A Real-World Evaluation of Risk Factors for Disease Progression in Patients with Polycythemia Vera (PV) Enrolled in REVEAL

Michael R. Grunwald, Jeffrey I. Zwicker, Aaron T. Gerds, John M. Burke, Zhenyi Xue, Erin L. Crowgey, Justine Carl, Patricia Feldman, Evan M. Braunstein, Stephen Oh

Blood (2023) 142 (Supplement 1): 385.

https://doi.org/10.1182/blood-2023-180215

Published: 2023

Journal Articles

Clinical and Disease Characteristics of Patients with Myelofibrosis and Essential Thrombocythemia Who Harbor a Calreticulin (CALR) Gene Mutation: Subanalysis of the MOST Study

Stephen T. Oh, Naveen Pemmaraju, Niyati Nathwani, Evan M. Braunstein, JE Hamer-Maansson, Tricia Kalafut, Ellen K. Ritchie

Blood (2023) 142 (Supplement 1): 3812.

https://doi.org/10.1182/blood-2023-179507

Published: 2023

Journal Articles

Ruxolitinib Treatment in Polycythemia Vera Results in Reduction in JAK2 Allele Burden in Addition to Improvement in Hematocrit Control and Symptom Burden

Claire N Harrison, Jean-Jacques Kiladjian, Francesca Palandri, JE Hamer-Maansson, Evan M. Braunstein, Francesco Passamonti

Blood (2023) 142 (Supplement 1): 4553.

https://doi.org/10.1182/blood-2023-179439

Published: 2023

Journal Articles

High Rate of Disease Progression in Patients with Low-Risk Myelofibrosis (MF) Enrolled in the Prospective, Real-World MOST Study

Michael R. Grunwald, Aaron T. Gerds, Apurv Agrawal, Evan M. Braunstein, JE Hamer-Maansson, Tricia Kalafut, John Mascarenhas

Blood (2023) 142 (Supplement 1): 3803.

https://doi.org/10.1182/blood-2023-174523

Published: 2023

Journal Articles

Progression to Myelofibrosis in Patients with Essential Thrombocythemia: A Real-World Analysis from the Prospective MOST Study

Abdulraheem Yacoub, Roger M. Lyons, Evan M. Braunstein, JE Hamer-Maansson, Tricia Kalafut, Ruben A. Mesa

Blood (2023) 142 (Supplement 1): 2433.

https://doi.org/10.1182/blood-2023-180240

Published: 2023

Journal Articles

Silent cerebral infarction during immune TTP remission: prevalence, predictors, and impact on cognition

Shruti Chaturvedi, Jia Yu, Jenna Brown, Aria Wei, Sruthi Selvakumar, Gloria F. Gerber, Alison R. Moliterno, Michael B. Streiff, Peggy Kraus, Claire M. Logue, Jennifer C. Yui, Rakhi P. Naik, Hira Latif, Sophie M. Lanzkron, Evan M. Braunstein, Robert A. Brodsky, Rebecca F. Gottesman, Doris D. Lin

Blood (2023) 142 (4): 325–335.

https://doi.org/10.1182/blood.2023019663

Published: 2023

Includes: Supplemental data

Journal Articles

Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition

Jia Yu, Jenna Brown, Eli Salzberg, Aria Wei, Gloria Gerber, Xiang-Zuo Pan, Alison R. Moliterno, MIchael B. Streiff, Peggy Kraus, Claire Logue, Jennifer Yui, Rakhi P.P. Naik, Hira Latif, Sophie M. Lanzkron, Evan M. Braunstein, Robert Brodsky, Michael R. DeBaun, Doris Lin, Shruti Chaturvedi

Blood (2022) 140 (Supplement 1): 338–340.

https://doi.org/10.1182/blood-2022-167054

Published: 2022

Journal Articles

SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura

Hridaya Shah, Ann Kim, Senthil Sukumar, Marshall Mazepa, Ruhail Kohli, Evan M. Braunstein, Robert A. Brodsky, Spero Cataland, Shruti Chaturvedi

Blood (2022) 139 (16): 2570–2573.

https://doi.org/10.1182/blood.2022015545

Published: 2022

Includes: Supplemental data

Journal Articles

Complement Activation Drives Progression of Pre-Eclampsia to HELLP Syndrome

Hridaya Shah, Theresa Boyer, Hang Chen, Shruti Chaturvedi, Arthur Vaught, Evan M. Braunstein

Blood (2021) 138 (Supplement 1): 772.

https://doi.org/10.1182/blood-2021-148162

Published: 2021

Journal Articles

Silent Cerebral Infarction on Brain MRI Is Associated with Cognitive Impairment in Ittp Survivors in Hematological Remission

Jia Yu, Aria Wei, Xiang-Zuo Pan, Gloria Frances Gerber, Sarah Hussain, Alison R. Moliterno, Michael B. Streiff, Peggy Kraus, Claire Logue, Jennifer Yui, Rakhi P. Naik, Hira Latif, Ruhail Kohli, Sophie M. Lanzkron, Evan M. Braunstein, Robert Brodsky, Doris Lin, Shruti Chaturvedi

Blood (2021) 138 (Supplement 1): 774.

https://doi.org/10.1182/blood-2021-151304

Published: 2021

Journal Articles

Whole Genome Sequencing Uncovers a Rare Germline Variant in ATM Associated with Familial Myeloproliferative Neoplasms

Shiyu Wang, Hang Chen, Eddie Imada, Jack Ghannam, Clifton L. Dalgard, Camille Alba, Christopher S. Hourigan, Luigi Marchionni, Alison R. Moliterno, Lukasz P. Gondek, Evan M. Braunstein

Blood (2021) 138 (Supplement 1): 3592.

https://doi.org/10.1182/blood-2021-153317

Published: 2021

NARROW

Cost Comparison of Ruxolitinib and Momelotinib in Patients with Myelofibrosis and Anemia

High Molecular Risk Mutations (HMR) Drive Progression of CALR -mutated Myeloproliferative Neoplasm (MPN)

Use of Natural Language Processing to Identify Myeloid/Lymphoid Neoplasm Patients with Fibroblast Growth Factor Receptor 1 Alterations

Genetic or Epigenetic CR1 Deficiency Defines Catastrophic Antiphospholipid Syndrome (CAPS) and Response to Complement Inhibition

Molecular Predictors of Disease Progression to Myelofibrosis (MF) in Patients (Pts) with Polycythemia Vera (PV) Enrolled in Reveal

Real-World Treatment Patterns and Blood Count Control in Patients with Polycythemia Vera Who Switched from Hydroxyurea to Ruxolitinib

Clinical and Molecular Characterization of Disease Progression in Patients (Pts) with Low-Risk Myelofibrosis (MF) Enrolled in the MOST Study

Clinical Outcomes in Patients with Myelofibrosis Treated with Ruxolitinib and Anemia-Supporting Medications

Effect of New or Worsening Anemia on Clinical Outcomes in 2233 Patients with Myelofibrosis Treated with Ruxolitinib in the Expanded-Access Jump Study

A Real-World Evaluation of Risk Factors for Disease Progression in Patients with Polycythemia Vera (PV) Enrolled in REVEAL

Clinical and Disease Characteristics of Patients with Myelofibrosis and Essential Thrombocythemia Who Harbor a Calreticulin (CALR) Gene Mutation: Subanalysis of the MOST Study

Ruxolitinib Treatment in Polycythemia Vera Results in Reduction in JAK2 Allele Burden in Addition to Improvement in Hematocrit Control and Symptom Burden

High Rate of Disease Progression in Patients with Low-Risk Myelofibrosis (MF) Enrolled in the Prospective, Real-World MOST Study

Progression to Myelofibrosis in Patients with Essential Thrombocythemia: A Real-World Analysis from the Prospective MOST Study

Silent cerebral infarction during immune TTP remission: prevalence, predictors, and impact on cognition

Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition

SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura

Complement Activation Drives Progression of Pre-Eclampsia to HELLP Syndrome

Silent Cerebral Infarction on Brain MRI Is Associated with Cognitive Impairment in Ittp Survivors in Hematological Remission

Whole Genome Sequencing Uncovers a Rare Germline Variant in ATM Associated with Familial Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only